HENDERSON, Nev., Oct. 13, 2023 /PRNewswire/ -- VolitionRx Limited (NYSEAMERICAN:VNRX) ("Volition"), a multi-national epigenetics company, has published a report summarising key themes from its recent Key Opinion Leader ("KOL") roundtable on sepsis management.
Read more at prnewswire.comVolition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here